Kevin Farthing, DO
Family Medicine · Prestonsburg, KYNPI 1629424429
Payments from drug & device makers
Across 426 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$812
- Pfizer$521
- GSK$459
- Biogen$321
- Biohaven Pharmaceutical Holding Company Ltd.$272
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,36499%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 135 | $1,903 |
| Lilly USA, LLC | 56 | $812 |
| Pfizer | 39 | $521 |
| GSK | 29 | $459 |
| Biogen | 19 | $321 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $272 |
| Amgen | 15 | $268 |
| AstraZeneca(2 entities) | 13 | $221 |
| Biohaven Pharmaceuticals, Inc. | 17 | $206 |
| Astellas Pharma US Inc | 10 | $165 |
| Novo Nordisk | 7 | $128 |
| Novartis | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $120 |
| Daiichi Sankyo Inc. | 6 | $93 |
| Boehringer Ingelheim | 5 | $77 |
| CSL Behring | 4 | $72 |
| Bayer | 5 | $68 |
| Abbott | 4 | $65 |
| SK Life Science, Inc. | 4 | $63 |
| Johnson & Johnson | 4 | $61 |
| Livanova USA, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| EMD Serono, Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| UCB, Inc. | 1 | $26 |
| Boston Scientific | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Adamas Pharmaceuticals, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$6,409 in reported general payments places this provider in the 85th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 127 | $131,561 |
| FarxigaDapagliflozin Propanediol | 132 | $102,021 |
| OzempicSemaglutide | 104 | $99,291 |
| EliquisApixaban | 118 | $94,734 |
| JardianceEmpagliflozin | 82 | $81,652 |
| LinzessLinaclotide | 78 | $68,290 |
| JanuviaSitagliptin Phosphate | 57 | $58,058 |
| TrulicityDulaglutide | 40 | $46,402 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 53 | $37,853 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $24,216 |
| XareltoRivaroxaban | 30 | $21,947 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 73 | $17,781 |
| Nurtec OdtRimegepant Sulfate | 13 | $14,491 |
| Spiriva HandihalerTiotropium Bromide | 19 | $13,278 |
| EntrestoSacubitril/Valsartan | 12 | $11,977 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $812 | $177,962167 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $221 | $143,392198 claims |
| PfizerEliquis, Nurtec Odt | $521 | $109,225131 claims |
| Novo NordiskOzempic | $128 | $99,291104 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta | $77 | $93,103105 claims |
| AbbVieLinzess, Restasis | $1,903 | $78,63991 claims |
| GSKTrelegy Ellipta | $459 | $24,21623 claims |
| Johnson & JohnsonXarelto | $61 | $21,94730 claims |
| NovartisEntresto | $121 | $11,97712 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $4,745603 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Prestonsburg
- Debra HallPrestonsburg$12K
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.